HyperglycemiaHypoglycemiaBlood GlucoseInsulinDiabetic KetoacidosisInsulin ComaDiabetes Mellitus, Type 2Hypoglycemic AgentsAcute DiseaseGlucoseDiabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalGlucose Clamp TechniqueHemoglobin A, GlycosylatedDiabetes MellitusInsulin, Long-ActingIslets of LangerhansInsulin Infusion SystemsBlood Glucose Self-MonitoringGlucose Tolerance TestGlucagonHeterogeneous-Nuclear Ribonucleoprotein KHyperinsulinismInsulin, Regular, PorkInsulin LisproTime FactorsGliclazideInfusions, SubcutaneousRats, Sprague-DawleyCongenital HyperinsulinismOxidative StressSulfonylurea CompoundsInsulin, IsophaneEpinephrineStreptozocinInsulin AntibodiesCritical IllnessHemodynamicsMyocardial InfarctionDiabetic AngiopathiesPancreatic PolypeptideC-PeptideIslets of Langerhans TransplantationAwarenessMetforminFastingGluconeogenesisRisk FactorsComaPostprandial PeriodRetrospective StudiesInsulin-Secreting CellsClinical AlarmsSeverity of Illness IndexTreatment OutcomeInsulin ResistanceGlucokinaseDiabetes ComplicationsDrug Administration ScheduleVentromedial Hypothalamic NucleusInjections, SubcutaneousHydrocortisoneSeizuresPregnancy in DiabeticsGlycosuriaBrain DiseasesInsulinomaBrainPancreas, ArtificialNesidioblastosisCognitionGlipizidePhlorhizinFatty Acids, NonesterifiedLiverGlucagon-Like Peptide 1HomeostasisPancreasBody WeightNorepinephrineDiazoxideIncidenceGlucose Intolerance3-Hydroxybutyric AcidInfusions, IntravenousReference ValuesDiabetic NephropathiesRats, Wistar